Merck & Co Inc MRK

NYSE US Health Care Pharmaceuticals

$148.78 ▲ +0.54% (+$0.80)

Index member: S&P 500

Open $148.06

Prev Close $147.98

Day Range $147.48 – $149.98

52W Range $77.58 – $156.92

Market Cap $363.04B

P/E (TTM) 115.20

Beta 0.14

Div Yield 2.87%

EPS (TTM) $1.25

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1941-01-01
Shares Out.	2,469,820,000
Website	merck.com/ ↗
Phone	19087404000
Employees	75,000
Revenue	$16.61B
Gross Profit	$12.21B
Net Income	-$1.34B
Free Cash Flow	$16.06B
Total Assets	$129.80B
Total Liabilities	$87.82B
Equity	$41.98B

About Merck & Co Inc

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Merck & Co Inc is a publicly traded company under the ticker symbol MRK on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.